Vycor Medical (VYCO) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -856.00 |
| Dec 31, 2025 | -785.00 |
| Sep 30, 2025 | 266.00 |
| Jun 30, 2025 | -795.00 |
| Mar 31, 2025 | -655.00 |
| Dec 31, 2024 | -145.00 |
| Sep 30, 2024 | -44.00 |
| Jun 30, 2024 | 11.00 |
| Mar 31, 2024 | -66.00 |
| Dec 31, 2023 | -273.00 |
| Sep 30, 2023 | -22.00 |
| Jun 30, 2023 | 733.00 |
| Mar 31, 2023 | 49.00 |
| Dec 31, 2022 | 1,758.00 |
| Sep 30, 2022 | 98.00 |
| Jun 30, 2022 | 432.00 |
| Mar 31, 2022 | 55.00 |
| Dec 31, 2021 | -244.00 |
| Sep 30, 2021 | 93.00 |
| Jun 30, 2021 | 467.00 |
| Mar 31, 2021 | 718.00 |
| Dec 31, 2020 | 686.00 |
| Sep 30, 2020 | -389.00 |
| Jun 30, 2020 | 349.00 |
| Mar 31, 2020 | 444.00 |
| Sep 30, 2019 | 519.00 |
| Jun 30, 2019 | 321.00 |
| Mar 31, 2019 | 167.00 |
| Dec 31, 2018 | 707.00 |
| Sep 30, 2018 | 274.00 |
| Jun 30, 2018 | -370.00 |
| Mar 31, 2018 | 393.00 |
| Dec 31, 2017 | -1,926.00 |
| Sep 30, 2017 | -307.00 |
| Jun 30, 2017 | 235.00 |
| Mar 31, 2017 | 716.00 |
| Dec 31, 2016 | 904.00 |
| Sep 30, 2016 | 418.00 |
| Jun 30, 2016 | 1,205.00 |
| Mar 31, 2016 | -139.00 |
| Dec 31, 2015 | -161.00 |
| Sep 30, 2015 | 601.00 |
| Jun 30, 2015 | -362.00 |